secwatch.observer — SEC 8-K summary
======================================

Issuer:     AGIOS PHARMACEUTICALS, INC. (AGIO)
CIK:        0001439222
Form:       8-K
Filed at:   2022-08-15T23:59:59+00:00
Accession:  0001193125-22-221224
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Agios Pharmaceuticals elects Rahul Ballal and Cynthia Smith as new directors
----------------------------------------------------------------------------

- Board elected Rahul Ballal, Ph.D. and Cynthia Smith as Class I directors on Aug 11, 2022, effective immediately.
- Each new director receives annual cash compensation of $50,000 and initial equity grants: 37,947 options at $25.99 and 6,906 RSUs.
- Options vest 25% on first anniversary, remainder over 36 months; RSUs vest 1/3 annually over three years.
- Both directors entered standard indemnification agreements with the Company.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1439222/000119312522221224/0001193125-22-221224-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1439222/000119312522221224/d339643d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-221224

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer